1000ug
GEN1194127.Yeast
2133€
Recombinant Human Putative type-1 protein phosphatase inhibitor 4 (PPP1R2P9)
Putative type-1 protein phosphatase inhibitor 4; Putative type-1 protein phosphatase inhibitor 4; Protein phosphatase 1, regulatory subunit 2 pseudogene 9
PPP1R2P9
PPP1R2P9; I-4
Putative type-1 protein phosphatase inhibitor 4(PPP1R2P9) is a recombinant protein expressed in Yeast . The protein can be with or without a His-Tag or other tag in accordance to customer's request. All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility.
Recombinant Proteins
Yeast
E Coli ; Yeast ; Baculovirus ; Mammalian Cell
Greater than 90% (determined by SDS-PAGE)
Lyophilized protein
This protein can be stored at -20 degrees Celsius. For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius. Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains.
This protein can be used as a positive control for applications such as ELISA, IFA, RIA, Western Blot, etc.
Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
